Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Tuesday 19th September 2017 from 8.00am to 4.00pm (BST).

During this time our website performance may be temporarily affected. If you have any questions please use the feedback button available under our menu button. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 7, 2012
Previous Article Next Article

Src homology 2 domain proteomimetics: developing phosphopeptide selective receptors

Author affiliations

Abstract

SH2 domains are the paradigm of phosphotyrosine protein recognition modules and are involved in mediating numerous cancer-promoting proteinprotein complexes. In an effort to develop protein-selective receptors for inhibition of protein complexation events, we herein report the de novo rational and computationally aided design of SH2 domain proteomimetics. Lead mimetics exhibit target phosphopeptide selectivity (Ka ≈ 107 M−1) and potently disrupt SH2 domain:phosphopeptide interactions.

Graphical abstract: Src homology 2 domain proteomimetics: developing phosphopeptide selective receptors

Back to tab navigation

Supplementary files

Publication details

The article was received on 22 Feb 2012, accepted on 29 Feb 2012 and first published on 04 Apr 2012


Article type: Concise Article
DOI: 10.1039/C2MD20052J
Citation: Med. Chem. Commun., 2012,3, 763-770
  •   Request permissions

    Src homology 2 domain proteomimetics: developing phosphopeptide selective receptors

    J. A. Drewry, S. Burger, A. Mazouchi, E. Duodu, P. Ayers, C. C. Gradinaru and P. T. Gunning, Med. Chem. Commun., 2012, 3, 763
    DOI: 10.1039/C2MD20052J

Search articles by author

Spotlight

Advertisements